Bioresorbable implants are temporary implants that are absorbed and metabolized by the body over time. Bioresorbable implants are commonly used in orthopedic surgeries such as bone fracture fixation and drug delivery. They help patients avoid the need for implant removal surgeries.

 

The global bioresorbable implants market is estimated to be valued at US$ 1399.4 Mn  in 2023 and is expected to exhibit a CAGR of 4.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Dynamics:

Rising number of orthopedic surgeries: The increasing prevalence of orthopedic disorders such as musculoskeletal injuries, spinal disorders, bone fractures and bone degeneration is driving the rising number of orthopedic surgeries globally. According to the Centers for Disease Control and Prevention (CDC), over 10,000 new hip fractures occur each year owing to osteoporosis in the United States alone. Bioresorbable implants are widely used in orthopedic surgeries which is fueling the market growth.

Superior properties of bioresorbable implants: Bioresorbable implants provide advantages over conventional metallic implants as they eliminate the need for implant removal surgeries due to which there is less post-operative discomfort and pain. Additionally, bioresorbable implants allow natural bone healing and remodeling as they degrade and get replaced by new bone over time without leaving any foreign material in the body.

SWOT Analysis
Strength: Bioresorbable implants that dissolve in the body over time reduce risks associated with permanent implant removal surgeries. They provide structural support to tissues during recovery and healing before gradually dissolving. Their material composition makes them compatible with surrounding tissues without triggering long-term foreign body responses.

Weakness: Existing bioresorbable materials like PLLA have low strength and break down slowly over years, requiring close medical monitoring. Developing high-strength bioresorbable alloys that completely dissolve within months poses technical challenges.

Opportunity: The growing elderly population susceptible to bone and joint issues drives demand. Increasing preference for minimally invasive procedures avoids permanent implant-related complications. Developing implants configurable for personalized medicine using 3D printing expands applications.

Threats: High research costs and regulatory hurdles associated with new biomaterial approval limits market entry. Reimbursement policies influence large-scale adoption. Permanent metallic implants remain entrenched alternatives in some procedures.

Key Takeaways
Global Bioresorbable Implants Market Size  is expected to witness high growth.

North America dominates currently due to advanced medical technology adoption and widespread device availability. However, Asia Pacific is poised to grow the fastest due to rising medical tourism, increasing health awareness and spending capabilities.

Key players operating in the bioresorbable implants market are Corbion, Evonik, Foster Corporation, DSM, Poly-Med, KLS Martin, and Lactic. The major players are focusing on developing enhanced material formulations that provide mechanical support equivalent to metals but fully degrade and pass out of the body safely in defined timeframes. They are also improving manufacturing processes to efficiently mass-produce customizable implant designs tailored for specific patient anatomies using 3D printing and computer modeling.


Explore More Related Article On This Topic: https://www.ukwebwire.com/bioresorbable-implants-market-scope/

 

Explore More Related Article On: https://articleblock.com/business/training-market-is-estimated-to-witness-high-growth/